| Feb 27, 2026 |
Mar 3, 2026 |
Cvijic Christine Mikail
|
CFO |
Sell |
38.8
|
-4,800
|
-4.19%
|
✓
|
$120.5K |
| Feb 20, 2026 |
Feb 24, 2026 |
Cobb Stuart
|
Chief Scientific Officer |
Neutral |
90.0
|
+16,500
|
79.35%
|
✗
|
- |
| Feb 20, 2026 |
Feb 24, 2026 |
Jordan Julie
|
Chief Medical Officer |
Neutral |
90.0
|
+4,900
|
58.33%
|
✗
|
- |
| Feb 20, 2026 |
Feb 24, 2026 |
Cvijic Christine Mikail
|
CFO |
Neutral |
90.0
|
+22,000
|
23.75%
|
✗
|
- |
| Feb 20, 2026 |
Feb 24, 2026 |
McMinn Rachel
|
CEO |
Neutral |
77.5
|
+25,900
|
1.96%
|
✗
|
- |
| Feb 20, 2026 |
Feb 24, 2026 |
PALEKAR ROHAN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 20, 2026 |
Feb 24, 2026 |
BAFFI ROBERT
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 20, 2026 |
Feb 24, 2026 |
Noonberg Sarah B.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 20, 2026 |
Feb 24, 2026 |
Freedland Cory S.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 20, 2026 |
Feb 24, 2026 |
Woods Keith
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 13, 2025 |
BAFFI ROBERT
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 13, 2025 |
Woods Robert Keith
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 13, 2025 |
PALEKAR ROHAN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 13, 2025 |
Freedland Cory S.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2025 |
Jun 13, 2025 |
Noonberg Sarah B.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 14, 2025 |
May 15, 2025 |
Cobb Stuart
|
Chief Scientific Officer |
Sell |
15.0
|
-6,797
|
-24.63%
|
✓
|
$103K |
| Mar 26, 2025 |
Mar 28, 2025 |
Cobb Stuart
|
Chief Scientific Officer |
Neutral |
90.0
|
+7,200
|
35.31%
|
✗
|
- |
| Mar 26, 2025 |
Mar 28, 2025 |
Cvijic Christine Mikail
|
CFO |
Neutral |
90.0
|
+20,300
|
28.06%
|
✗
|
- |
| Mar 26, 2025 |
Mar 28, 2025 |
Jordan Julie
|
Chief Medical Officer |
Neutral |
90.0
|
+8,400
|
100.00%
|
✗
|
- |
| Mar 26, 2025 |
Mar 28, 2025 |
McMinn Rachel
|
CEO |
Neutral |
77.5
|
+23,900
|
1.91%
|
✗
|
- |
| Mar 13, 2025 |
Mar 17, 2025 |
Cvijic Christine Mikail
|
CFO |
Sell |
42.5
|
-4,501
|
-5.86%
|
✗
|
$76.2K |
| Nov 26, 2024 |
Nov 27, 2024 |
Samsara BioCapital GP, LLC
|
10% Owner |
Buy |
92.5
|
+48,770
|
2.92%
|
✗
|
$1.3M |
|
Nov 27, 2024 |
Samsara BioCapital GP, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 22, 2024 |
Nov 25, 2024 |
Cvijic Christine Mikail
|
CFO |
Buy |
97.5
|
+24,000
|
45.42%
|
✗
|
$491.4K |
| Nov 22, 2024 |
Nov 25, 2024 |
McMinn Rachel
|
CEO |
Buy |
90.0
|
+47,500
|
3.80%
|
✗
|
$969K |
| Jun 14, 2024 |
Jun 17, 2024 |
Woods Robert Keith
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2024 |
Jun 17, 2024 |
PALEKAR ROHAN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2024 |
Jun 17, 2024 |
BAFFI ROBERT
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2024 |
Jun 17, 2024 |
Noonberg Sarah B.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2024 |
Jun 17, 2024 |
Freedland Cory S.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 13, 2024 |
Mar 14, 2024 |
McMinn Rachel
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 13, 2024 |
Mar 14, 2024 |
Cvijic Christine Mikail
|
CFO |
Neutral |
90.0
|
+31,903
|
152.35%
|
✗
|
- |
| Mar 13, 2024 |
Mar 14, 2024 |
Cobb Stuart
|
Chief Scientific Officer |
Neutral |
90.0
|
+20,391
|
100.00%
|
✗
|
- |
| Jan 16, 2024 |
Jan 18, 2024 |
Woods Robert Keith
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2024 |
Jan 18, 2024 |
PALEKAR ROHAN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2024 |
Jan 18, 2024 |
Noonberg Sarah B.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2024 |
Jan 18, 2024 |
Freedland Cory S.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2024 |
Jan 18, 2024 |
BAFFI ROBERT
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2024 |
Jan 18, 2024 |
Jordan Julie
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 18, 2024 |
Jordan Julie
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 26, 2023 |
Cvijic Christine Mikail
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 26, 2023 |
McMinn Rachel
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 26, 2023 |
Woods Robert Keith
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 26, 2023 |
BAFFI ROBERT
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 26, 2023 |
Cobb Stuart
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 26, 2023 |
Freedland Cory S.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 18, 2023 |
Dec 20, 2023 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 5, 2023 |
Oct 10, 2023 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 15, 2023 |
Aug 17, 2023 |
BAKER BROS. ADVISORS LP
|
Director |
Buy |
95.0
|
+2,285,342
|
6.89%
|
✗
|
$1.5M |
| Aug 10, 2023 |
Aug 14, 2023 |
Smith Sean Michael
|
CFO |
Sell |
47.5
|
-1,323
|
-5.76%
|
✗
|
$818.1 |
| Jun 8, 2023 |
Jun 12, 2023 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 8, 2023 |
Jun 9, 2023 |
SIMPSON TODD E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 8, 2023 |
Jun 9, 2023 |
PALEKAR ROHAN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 8, 2023 |
Jun 9, 2023 |
Noonberg Sarah B.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 8, 2023 |
Jun 9, 2023 |
Lavelle Erin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 8, 2023 |
Jun 9, 2023 |
Babler Martin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 31, 2023 |
Apr 4, 2023 |
Patel Priti
|
Other |
Sell |
47.5
|
-3,769
|
-9.17%
|
✗
|
$2.6K |
| Feb 1, 2023 |
Feb 3, 2023 |
Smith Sean Michael
|
Principal Accounting Officer |
Sell |
47.5
|
-3,316
|
-17.20%
|
✗
|
$2K |
| Feb 1, 2023 |
Feb 3, 2023 |
Patel Priti
|
Chief Medical Officer |
Sell |
47.5
|
-14,380
|
-31.63%
|
✗
|
$8.6K |
| Aug 10, 2022 |
Aug 12, 2022 |
Smith Sean Michael
|
Principal Accounting Officer |
Sell |
47.5
|
-1,655
|
-19.63%
|
✗
|
$1.6K |
| Aug 2, 2022 |
Aug 4, 2022 |
Walkey Carl
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 2, 2022 |
Aug 4, 2022 |
Smith Sean Michael
|
Principal Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 2, 2022 |
Aug 4, 2022 |
Patel Priti
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 2, 2022 |
Aug 4, 2022 |
DRACHMAN JONATHAN G
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 2, 2022 |
Aug 4, 2022 |
Cochener Donna
|
General Counsel, SVP Legal |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 12, 2022 |
May 16, 2022 |
SIMPSON TODD E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 12, 2022 |
May 16, 2022 |
PALEKAR ROHAN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 12, 2022 |
May 16, 2022 |
Noonberg Sarah B.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 12, 2022 |
May 16, 2022 |
Lavelle Erin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 12, 2022 |
May 16, 2022 |
Babler Martin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 12, 2022 |
May 16, 2022 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 30, 2022 |
May 3, 2022 |
Patel Priti
|
Chief Medical Officer |
Sell |
47.5
|
-5,538
|
-46.15%
|
✗
|
$6.7K |
| Mar 14, 2022 |
Mar 15, 2022 |
Cochener Donna
|
General Counsel, SVP Legal |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 15, 2022 |
Cochener Donna
|
General Counsel, SVP Legal |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 2, 2022 |
Mar 4, 2022 |
PALEKAR ROHAN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 4, 2022 |
PALEKAR ROHAN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 2, 2022 |
Mar 3, 2022 |
Smith Sean Michael
|
Principal Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 3, 2022 |
Smith Sean Michael
|
Principal Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 26, 2021 |
Feb 14, 2022 |
DRACHMAN JONATHAN G
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2022 |
Feb 2, 2022 |
Walkey Carl
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2022 |
Feb 2, 2022 |
Patel Priti
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2022 |
Feb 2, 2022 |
Ho Robert
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 24, 2021 |
Aug 26, 2021 |
DRACHMAN JONATHAN G
|
CEO |
Buy |
92.5
|
+150,000
|
6.67%
|
✗
|
$933.6K |
| Aug 3, 2021 |
Aug 5, 2021 |
Walkey Carl
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 3, 2021 |
Aug 5, 2021 |
Vance Holly
|
General Counsel |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 3, 2021 |
Aug 5, 2021 |
Patel Priti
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 3, 2021 |
Aug 5, 2021 |
Ho Robert
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 3, 2021 |
Aug 5, 2021 |
DRACHMAN JONATHAN G
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2021 |
Jun 17, 2021 |
Walkey Carl
|
President |
Sell |
58.8
|
-600
|
-0.04%
|
✓
|
$6.1K |
| Jun 9, 2021 |
Jun 11, 2021 |
Walkey Carl
|
President |
Sell |
58.8
|
-650
|
-0.05%
|
✓
|
$7K |
| Jun 8, 2021 |
Jun 9, 2021 |
Walkey Carl
|
President |
Sell |
58.8
|
-600
|
-0.04%
|
✓
|
$6.6K |
| Jun 4, 2021 |
Jun 7, 2021 |
Walkey Carl
|
President |
Sell |
58.8
|
-600
|
-0.04%
|
✓
|
$6K |
| Jun 3, 2021 |
Jun 7, 2021 |
DRACHMAN JONATHAN G
|
CEO |
Buy |
85.0
|
+50,000
|
2.27%
|
✗
|
$475.4K |
| May 26, 2021 |
May 26, 2021 |
Walkey Carl
|
President |
Sell |
58.8
|
-600
|
-0.04%
|
✓
|
$6K |
| May 19, 2021 |
May 21, 2021 |
Walkey Carl
|
President |
Sell |
58.8
|
-600
|
-0.04%
|
✓
|
$6.4K |
| May 11, 2021 |
May 13, 2021 |
Williams Lewis T
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 11, 2021 |
May 13, 2021 |
SIMPSON TODD E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 11, 2021 |
May 13, 2021 |
Noonberg Sarah B.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 11, 2021 |
May 13, 2021 |
Lavelle Erin M.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 11, 2021 |
May 13, 2021 |
Babler Martin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |